Meta-analysis on Effectiveness and Safety of Moxifloxacin in Treatment of Multidrug Resistant Tuberculosis in Adults

BACKGROUND: Moxifloxacin, a fourth generation fluoroquinolone, which has good antibacterial activity against both Gram-positive cocci and Gram-negative bacteria. To date, there are no meta-analysis to evaluate the efficacy and safety of moxifloxacin for multi-drug resistant tuberculosis (MDR-TB) tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Yanmin, Liu, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310829/
https://www.ncbi.nlm.nih.gov/pubmed/32569195
http://dx.doi.org/10.1097/MD.0000000000020648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310829/
https://www.ncbi.nlm.nih.gov/pubmed/32569195
http://dx.doi.org/10.1097/MD.0000000000020648

Ejemplares similares